1Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
2Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA.
3Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
4Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Copyright © 2018 Korean Diabetes Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported.
Values are presented as mean±standard deviation, number (%), or median (interquartile range).
CAN, cardiovascular autonomic neuropathy; BMI, body mass index; WC, waist circumference; WHR, waist-hip ratio; BP, blood pressure; HbA1c, glycosylated hemoglobin; eGFR, estimated glomerular filtration rate; MDRD, Modification of Diet in Renal Disease; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; CAD, coronary artery disease; CVA, cerebrovascular accident; OHA, oral hypoglycemic agent.
Model 1: adjusted for age, sex, and BMI; Model 2: adjusted for model 1+diabetes duration and mean serial HbA1c; Model 3: adjusted for model 2+heart rate, eGFR, diabetic retinopathy, coronary artery disease, diabetes treatment (insulin use), and use of hypertension medication.
HbA1c, glycosylated hemoglobin; SD, standard deviation; OR, odds ratio; CI, confidence interval; CAN, cardiovascular autonomic neuropathy; BMI, body mass index; eGFR, estimated glomerular filtration rate.
aP<0.05, bP<0.01.
bModel 1: adjusted for age, sex, and BMI; Model 2: adjusted for model 1+diabetes duration and mean serial HbA1c; Model 3: adjusted for model 2+heart rate, eGFR, diabetic retinopathy, coronary artery disease, diabetes treatment (insulin use), and use of hypertension medication.
HbA1c, glycosylated hemoglobin; SD, standard deviation; OR, odds ratio; CI, confidence interval; CAN, cardiovascular autonomic neuropathy.
aP<0.05, bP<0.01.